Idera Pharmaceuticals announces closing of public offering of common stock and pre-funded warrants

11-02-2014 Business Wire HealthComments (0)

Idera PharmaceuticalsPharmaceuticalUSA

Idera Pharmaceuticals (NASDAQ: IDRA) today announced the closing of its previously announced underwritten public offering of 7,867,438 shares of common stock at an offering price of $4.00 per share, and pre-funded warrants to purchase up to an aggregate of 2,158,750 shares of common stock at an offering price of $3.99 per pre-funded warrant, which is the per share public offering price for the common stock less the $0.01 per sh

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top